Affiliation:
1. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114
2. Harvard Medical School, Boston, Massachusetts 02115
3. Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215
Abstract
ABSTRACT
Candida albicans
colonizes the human gastrointestinal tract and can cause life-threatening systemic infection in susceptible hosts. We study here
C. albicans
virulence determinants using the nematode
Caenorhabditis elegans
in a pathogenesis system that models candidiasis. The yeast form of
C. albicans
is ingested into the
C. elegans
digestive tract. In liquid media, the yeast cells then undergo morphological change to form hyphae, which results in aggressive tissue destruction and death of the nematode. Several lines of evidence demonstrate that hyphal formation is critical for
C. albicans
pathogenesis in
C. elegans
. First, two yeast species unable to form hyphae (
Debaryomyces hansenii
and
Candida lusitaniae
) were less virulent than
C. albicans
in the
C. elegans
assay. Second, three
C. albicans
mutant strains compromised in their ability to form hyphae (
efg1Δ/efg1Δ
,
flo8Δ/flo8Δ
, and
cph1Δ/cph1Δ efg1Δ/efg1Δ
) were dramatically attenuated for virulence. Third, the conditional
tet-NRG1
strain, which enables the external manipulation of morphogenesis in vivo, was more virulent toward
C. elegans
when the assay was conducted under conditions that permit hyphal growth. Finally, we demonstrate the utility of the
C. elegans
assay in a screen for
C. albicans
virulence determinants, which identified several genes important for both hyphal formation in vivo and the killing of
C. elegans
, including the recently described
CAS5
and
ADA2
genes. These studies in a
C. elegans-C. albicans
infection model provide insights into the virulence mechanisms of an important human pathogen.
Publisher
American Society for Microbiology
Subject
Molecular Biology,General Medicine,Microbiology
Reference52 articles.
1. Aballay, A., and F. M. Ausubel. 2002. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr. Opin. Microbiol.5:97-101.
2. Arendrup, M., T. Horn, and N. Frimodt-Moller. 2002. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection30:286-291.
3. Berman, J., and P. E. Sudbery. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet.3:918-930.
4. Braun, B. R., W. S. Head, M. X. Wang, and A. D. Johnson. 2000. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics156:31-44.
5. Braun, B. R., D. Kadosh, and A. D. Johnson. 2001. NRG1, a repressor of filamentous growth in Candida albicans, is downregulated during filament induction. EMBO J.20:4753-4761.
Cited by
167 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献